149 related articles for article (PubMed ID: 20823408)
1. Recurrent scrotal hemangiomas during treatment with sunitinib.
Tonini G; Intagliata S; Cagli B; Segreto F; Perrone G; Onetti Muda A; Santini D; Persichetti P
J Clin Oncol; 2010 Dec; 28(35):e737-8. PubMed ID: 20823408
[No Abstract] [Full Text] [Related]
2. Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
Bozas G; Roy A; Ramasamy V; Maraveyas A
Onkologie; 2010; 33(6):321-3. PubMed ID: 20523097
[TBL] [Abstract][Full Text] [Related]
3. Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy.
Mignogna MD; Fedele S; Lo Russo L; Ciccarelli R; Lo Muzio L
J Clin Oncol; 2006 Mar; 24(9):1475-7. PubMed ID: 16549843
[No Abstract] [Full Text] [Related]
4. Pyoderma gangrenosum with the use of sunitinib.
Nadauld LD; Miller MB; Srinivas S
J Clin Oncol; 2011 Apr; 29(10):e266-7. PubMed ID: 21220606
[No Abstract] [Full Text] [Related]
5. Acute cardiac failure after sunitinib.
Machiels JP; Bletard N; Pirenne P; Jacquet L; Bonbled F; Duck L
Ann Oncol; 2008 Mar; 19(3):597-9. PubMed ID: 18272908
[No Abstract] [Full Text] [Related]
6. Reversible posterior leukoencephalopathy syndrome induced by sunitinib.
Martín G; Bellido L; Cruz JJ
J Clin Oncol; 2007 Aug; 25(23):3559. PubMed ID: 17687168
[No Abstract] [Full Text] [Related]
7. Osteonecrosis of the jaws in patients assuming bisphosphonates and sunitinib: two case reports.
Agrillo A; Nastro Siniscalchi E; Facchini A; Filiaci F; Ungari C
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):952-7. PubMed ID: 22953645
[TBL] [Abstract][Full Text] [Related]
8. Scrotal cutaneous toxicity: an uncommon but important side-effect of sunitinib.
Gupta V; Rao A; Gupta S
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):132-3. PubMed ID: 25060046
[No Abstract] [Full Text] [Related]
9. Skin depigmentation induced by sunitinib treatment of renal cell carcinoma.
Al Enazi MM; Kadry R; Mitwali H
J Am Acad Dermatol; 2009 Nov; 61(5):905-6. PubMed ID: 19836653
[No Abstract] [Full Text] [Related]
10. Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report.
Kijima T; Fujii Y; Suyama T; Okubo Y; Yonese J; Fukui I
Int J Urol; 2008 Jun; 15(6):546-7. PubMed ID: 18489646
[TBL] [Abstract][Full Text] [Related]
11. Sunitinib-induced subungual splinter haemorrhage and acral erythema.
Nakamura M; Miyachi Y
Eur J Dermatol; 2008; 18(3):344-5. PubMed ID: 18474471
[No Abstract] [Full Text] [Related]
12. [Treatment with sunitinib and hypothyroidism--a case report and overview of literature].
Kreze A; Stáhalová V; Zadrazilová A; Koskuba J; Kosák M
Klin Onkol; 2009; 22(4):176-8. PubMed ID: 19731880
[TBL] [Abstract][Full Text] [Related]
13. Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.
Vickers MM; Heng DY; Hemmelgarn B; Eigl BJ
Clin Genitourin Cancer; 2009 Oct; 7(3):E104-6. PubMed ID: 19815480
[TBL] [Abstract][Full Text] [Related]
14. Genital and inguinal cutaneous toxicity in male and female patients treated with sunitinib.
Iacovelli R; Mancini ML; Risi E; Palazzo A; Cortesi E
Int J Dermatol; 2012 Feb; 51(2):221-2. PubMed ID: 22250635
[TBL] [Abstract][Full Text] [Related]
15. Reversible myocardial dysfunction in a young woman with metastatic renal cell carcinoma treated with sunitinib.
Szmit S; Nurzyński P; Szaluś N; Opolski G; Szczylik C
Acta Oncol; 2009; 48(6):921-5. PubMed ID: 19191048
[No Abstract] [Full Text] [Related]
16. A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
Ueharaguchi Y; Kabashima K; Sasahashi M; Matsuda A; Matubara K; Matsui M
Int J Dermatol; 2013 May; 52(5):634-6. PubMed ID: 23590380
[No Abstract] [Full Text] [Related]
17. Scrotal cutaneous side effects of sunitinib.
Billemont B; Barete S; Rixe O
N Engl J Med; 2008 Aug; 359(9):975-6; discussion 976. PubMed ID: 18753659
[No Abstract] [Full Text] [Related]
18. Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma.
Yıldız I; Varol U; Şen F; Kılıç L
Anadolu Kardiyol Derg; 2014 Nov; 14(7):654-6. PubMed ID: 25163084
[No Abstract] [Full Text] [Related]
19. Response to 'Thyrotoxicosis during sunitinib treatment for renal cell carcinoma' by Grossmann et al.
Daniels GH
Clin Endocrinol (Oxf); 2009 Sep; 71(3):455. PubMed ID: 19138312
[No Abstract] [Full Text] [Related]
20. Exfoliative esophagitis in a patient with metastatic renal cell carcinoma during sunitinib treatment.
Huang J; Wang T; Huang Y
Med Oncol; 2013 Mar; 30(1):436. PubMed ID: 23283650
[No Abstract] [Full Text] [Related]
[Next] [New Search]
